je.st
news
CytRx Announces the Presentation of Favorable Results from Novel...
2013-06-04 14:05:23| Logistics - Topix.net
CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, announced that preliminary results from a Phase 1b clinical trial determined that aldoxorubicin, the Company's improved version of the widely used chemotherapeutic agent doxorubicin, administered at 90% of its single agent dose can be safely delivered ... (more)
Tags: results
presentation
novel
favorable
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||